908 DEVICES INC

908 Devices Inc. boosts market presence—Nasdaq share sale, aerospace symposium showcase, and innovative chemical & biomolecular analytics for life sciences.

908 Devices Inc. sees senior VP boost stake, buy 83k shares amid stable stock at $7.09—key insider move signals confidence in future growth and market expansion.

908 Devices Inc. has recently been acquired by Repligen, with its stock price currently at $5.31 USD, reflecting a decline from its 52-week high and presenting challenges in profitability and valuation.